Stock Traders Buy High Volume of Call Options on Enovix (NASDAQ:ENVX)

Enovix Corporation (NASDAQ:ENVX) was the recipient of some unusual options trading activity on Friday. Stock traders bought 29,720 call options on the stock. This is an increase of approximately 92% compared to the average daily volume of 15,487 call options.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of Enovix by 10.9% during the fourth quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock worth $129,831,000 after acquiring an additional 1,747,145 shares during the period. Electron Capital Partners LLC boosted its position in Enovix by 13.8% during the third quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock valued at $80,143,000 after purchasing an additional 972,103 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Enovix by 6.1% in the 4th quarter. Geode Capital Management LLC now owns 4,413,492 shares of the company’s stock valued at $32,268,000 after buying an additional 253,906 shares in the last quarter. State Street Corp grew its holdings in Enovix by 2.0% in the fourth quarter. State Street Corp now owns 3,959,029 shares of the company’s stock worth $28,941,000 after purchasing an additional 77,079 shares during the last quarter. Finally, Royal Bank of Canada increased its position in Enovix by 18.0% during the 4th quarter. Royal Bank of Canada now owns 2,525,268 shares of the company’s stock valued at $18,461,000 after buying an additional 385,983 shares in the last quarter. 50.92% of the stock is currently owned by institutional investors.

Enovix Trading Down 9.3%

ENVX traded down $0.41 on Friday, hitting $3.94. The company had a trading volume of 6,154,207 shares, compared to its average volume of 6,391,066. The company has a market cap of $858.42 million, a PE ratio of -4.74 and a beta of 2.26. The company has a quick ratio of 10.65, a current ratio of 10.97 and a debt-to-equity ratio of 2.14. The business’s fifty day simple moving average is $6.25 and its 200 day simple moving average is $6.27. Enovix has a 12-month low of $3.92 and a 12-month high of $15.40.

Enovix (NASDAQ:ENVX) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.01. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The company had revenue of $7.60 million for the quarter, compared to analyst estimates of $6.95 million. During the same quarter in the prior year, the firm posted ($0.15) EPS. Enovix’s quarterly revenue was up 49.1% compared to the same quarter last year. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Equities research analysts expect that Enovix will post -0.79 EPS for the current year.

Wall Street Analysts Forecast Growth

ENVX has been the topic of a number of research reports. JPMorgan Chase & Co. downgraded shares of Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. TD Cowen decreased their price target on shares of Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday. Weiss Ratings restated a “sell (e+)” rating on shares of Enovix in a research report on Wednesday, July 8th. Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th. Finally, Benchmark decreased their target price on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Six research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $12.50.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.